BDF
SBRA icon

Balasa Dinverno & Foltz’s Sabra Healthcare REIT SBRA Stock Holding History

Balasa Dinverno & Foltz’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,945
Closed -$330K – 260
2019
Q1 		$330K Buy
+16,945
New +$321K 0.04% 177

Other funds holding SBRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Balasa Dinverno & Foltz's SBRA Position: Q2 2019 in Review

Balasa Dinverno & Foltz sold out of Sabra Healthcare REIT (SBRA) in Q2 2019, closing a stake of 16,945 shares — an estimated $330K sold.

Balasa Dinverno & Foltz first reported a position in SBRA in Q1 2019 and held it in 1 quarter. The position peaked at $330K in Q1 2019. 309 funds tracked by Wall St. Rank hold SBRA as of Q2 2019.

  • Balasa Dinverno & Foltz reported no remaining Sabra Healthcare REIT position as of Q2 2019 after selling out during the quarter.
  • Balasa Dinverno & Foltz sold 16,945 Sabra Healthcare REIT shares in Q2 2019, an estimated $330K.
  • Balasa Dinverno & Foltz first reported a position in Sabra Healthcare REIT in Q1 2019 and held it in 1 quarter.
  • Balasa Dinverno & Foltz's Sabra Healthcare REIT position peaked at $330K in Q1 2019.
  • 309 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2019.

Based on Balasa Dinverno & Foltz's 13F filing for Q2 2019, filed 7 Aug 2019.